Clopidogrel Bisulfate 97%
6 Inquiries
120202-66-6
Pharmaceutical Grade
97%
Any China Port
1kg/Papper Bag
2020-01-27
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Clopidogrel bisulfate
Other Name:Thieno[3,2-c]pyridine-5(4H)-acetic acid,α-(2-chlorophenyl)-6,7-dihydro-,methyl ester,(αS)-,sulfate (1:1);Thieno[3,2-c]pyridine-5(4H)-acetic acid,α-(2-chlorophenyl)-6,7-dihydro-,methyl ester,(S)-,sulfate (1:1);SR 25990C;Clopidogrel hydrogen sulfate;Clopidogrel bisulfate;Plavix;Clopidogrel hemisulfate;Iscover;(S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate;(S)-(+)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate;Methyl (S)-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)(2-chlorophenyl)ethanoate hydrogen sulfate;(S)-(+)-Clopidogrel hydrogen sulfate;Myogrel;Stroka;Clopidogrel sulfate;Plavitor;(+)-(S)-5-[(2-Chlorophenyl)(methoxycarbonyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]-pyridin-5-ium hydrogen sulfate];Clopidix;Areplex;Trombex;Zyllt
CAS No.:120202-66-6
Molecular Formula:C16H16ClNO2S.H2O4S
InChIKeys:InChIKey=FDEODCTUSIWGLK-RSAXXLAASA-N
Molecular Weight:419.9
Exact Mass:419.026398
EC Number:1806241-263-5
UNII:08I79HTP27
NSC Number:758613
DSSTox ID:DTXSID4046024
NCI Thesaurus Code:C2673
ATC Code:B01AC04|B01AC30
HScode:2942000000
Categories:
Characteristics-
PSA:
140.76000
XLogP3:3.96550
Appearance:white solid
Melting Point:184 °C
Boiling Point:423.7ºC at 760 mmHg
Flash Point:210ºC
Water Solubility:DMSO: ~26 mg/mL
Storage Conditions:2-8°C
Vapor Pressure:2.9X10-7 mm Hg at 25 °C (est)
Specific rotation:Specific optical rotation at 25 °C for D (sodium) line = +55.10 deg (c = 1.61 in methanol)
Collision Cross Section:167.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Acute toxicity - Category 4, Dermal
Acute toxicity - Category 4, Inhalation
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H312 Harmful in contact with skin
H332 Harmful if inhaled
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P317 Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Location:
Chengguan Town, Wuqing District, Tianjin Province, China
-
Payment Terms:
TT against copy of documents,O/A
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
101-200
-
Year of Establishment:
2004
-
Certifications:
China Great Wall (Tianjin) Quality Assurance Center Environment Management System Certification,HALAL,KOSHER,GMP,GMP,GMP,GMP
Tianjin Zhongrui Pharmaceutical co., Ltd. is a professional productive enterprise which dedicates to manufacture pharmaceutical ingredients and intermediates, and established in 2004 with total registered capital of CNY 26 million. The legal representative is Liu Changsuo and chief founders are natural persons from Beijing. Company’s main products include Niacin, Niacinamide , Inositol Nicotinate, Terazosin Hcl, Amifostine, Strontium Renalate, Cisatracurium Besilate, Fasudil Hcl, Clopidogrel hydrogen sulfate, Dopamine Hcl, Febuxostat, etc.
Tianjin Zhongrui serves as an integrated pharmaceutical manufacturer, owning advanced production equipments, "GMP" workshops, and various sophisticated testing instruments. Most company leadership team members are professional and technical with rich experience in pharmaceutical, gaining college degree or above education. The site covers a total area of 21000㎡, of which production workshops 1656 ㎡, QC laboratory 360㎡. Production lines of all raw materials are equipped with special equipments and independent air conditioning system. Our quality control capability is qualified to the production scale. All products pass the GMP certification. Our facility conditions conform to the requirements of the technology, production safety, environmental protection. Internal research institute is equipped with advanced R&D equipments and pilot plant.
Tianijn Zhongrui relies on strong technical force, high-quality work team, perfect quality assurance system to build ourselves as a high-tech enterprise. Therefor the company has achieved rapidly development.
In 2009, Tianjin Zhongrui was identified as high-tech enterprises, and passed the reexamination in 2012. New production technology of Nicotinamide was incorporated into science and technology innovation projects of Tianjin Science and Technology Commission. Strontium Ranelate gets supported by “technology personnel service enterprise action” project of Ministry of Science. The company spent more than CNY3 million on R&D in 2012.
In 2009, in order to introduce the advanced production technology of new drugs and pursue the better development, Tianjin Zhongrui cooperated with a technology-based private institute from Beijing, which is specialized in new drug research and development. This institute invested six new drug’s research achievements and CNY6 million to Tianjin Zhongrui, which injected a huge fresh vitality of science and technology.
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
India
Clopidogrel Bisulfate
2 MT Jun 5, 2025
India
Clopidogrel Bisulfate
10 G Nov 26, 2025
India
CLOPIDOGREL BISULPHATE
50 KG May 30, 2025
India
Clopidogrel Bisulfate
5 MG May 29, 2026
India
Methyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate(Clopidogre
1100 KG Jun 20, 2025
Vietnam
Clopidogrel bisulfate
100 KG Nov 27, 2023 Post an enquiry for this product